| Literature DB >> 28871484 |
Agnieszka Boś-Liedke1,2, Magdalena Walawender3, Anna Woźniak3, Dorota Flak3, Jacek Gapiński3,4, Stefan Jurga3,4, Małgorzata Kucińska5, Adam Plewiński5, Marek Murias5, Marwa Elewa6, Lisa Lampp7, Peter Imming7, Krzysztof Tadyszak8,9.
Abstract
Oxygenation is one of the most important physiological parameters of biological systems. Low oxygen concentration (hypoxia) is associated with various pathophysiological processes in different organs. Hypoxia is of special importance in tumor therapy, causing poor response to treatment. Triaryl methyl (TAM) derivative radicals are commonly used in electron paramagnetic resonance (EPR) as sensors for quantitative spatial tissue oxygen mapping. They are also known as magnetic resonance imaging (MRI) contrast agents and fluorescence imaging compounds. We report the properties of the TAM radical tris(2,3,5,6-tetrachloro-4-carboxy-phenyl)methyl, (PTMTC), a potential multimodal (EPR/fluorescence) marker. PTMTC was spectrally analyzed using EPR and characterized by estimation of its sensitivity to the oxygen in liquid environment suitable for intravenous injection (1 mM PBS, pH = 7.4). Further, fluorescent emission of the radical was measured using the same solvent and its quantum yield was estimated. An in vitro cytotoxicity examination was conducted in two cancer cell lines, HT-29 (colorectal adenocarcinoma) and FaDu (squamous cell carcinoma) and followed by uptake studies. The stability of the radical in different solutions (PBS pH = 7.4, cell media used for HT-29 and FaDu cells culturing and cytotoxicity procedure, full rat blood and blood plasma) was determined. Finally, a primary toxicity test of PTMTC was carried out in mice. Results of spectral studies confirmed the multimodal properties of PTMTC. PTMTC was demonstrated to be not absorbed by cancer cells and did not interfere with luciferin-luciferase based assays. Also in vitro and in vivo tests showed that it was non-toxic and can be freely administrated till doses of 250 mg/kg BW via both i.v. and i.p. injections. This work illustrated that PTMTC is a perfect candidate for multimodal (EPR/fluorescence) contrast agent in preclinical studies.Entities:
Keywords: Cytotoxicity; EPR oximetry; Oxygenation sensor; TAM derivative
Mesh:
Substances:
Year: 2017 PMID: 28871484 PMCID: PMC5913390 DOI: 10.1007/s12013-017-0824-3
Source DB: PubMed Journal: Cell Biochem Biophys ISSN: 1085-9195 Impact factor: 2.194
Fig. 1Molecular structure of PTMTC optimized in Gaussian visualized in GaussView (gray C, green Cl, red O, and white H) [30]. Inset shows radial distance through space from the center C atom with sources of isotropic shfs (color figure online)
Fig. 2a EPR signal of PTMTC in PBS solution pH 7.4 (~18.5% O2) inset: b free induction decay (T 2* = (21 ± 1) ns); c T 1 = (63 ± 7) ns (from FID—saturation); d powder EPR line and simulation
Isotropic hyper- and super hyperfine coupling constants (ν = 1.09 GHz, 18.5% O2)
| No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
|---|---|---|---|---|---|---|---|---|---|
| B [G] | 382.63 | 383.95 | 388.00 | 388.46 | 389.60 | 390.78 | 391.29 | 394.61 | 395.76 |
| ΔB [G] | 0.46 | 0.46 | 0.21 | 0.22 | 0.47 | 0.22 | 0.21 | 0.46 | 0.46 |
| A [a. u.] | 0.016 | 0.030 | 0.0022 | 0.0075 | 1 | 0.0075 | 0.0022 | 0.030 | 0.016 |
| I [a. u.] | 0.0034 | 0.0063 | 97 × 10−6 | 0.00036 | 0.22 | 0.00036 | 97 × 10−6 | 0.0063 | 0.0034 |
| a1 [G] | 2.32 | ||||||||
| a2 [G] | 3.29 | ||||||||
| a3 [G] | 10.66 | ||||||||
| a4 [G] | 13.08 | ||||||||
No. is the number of line in the Fig. 2, B is the field where the signal appears, ΔB is the peak–peak linewidth, A is the amplitude, I is the intensity from equation [31], ai is the isotropic Fermi coupling constants. For the assignment of couplings No. 1–9 to 13C atoms in PTMTC, see [32]
Fig. 3Central line broadening of the main EPR line component; (inset) linewidth vs. saturation with oxygen in PBS pH 7.4
Stability of the radical in different solutions
| Time | 0 (h) | 24 | 48 | 72 | 93.5 | |
|---|---|---|---|---|---|---|
| Solvent | % | % | % | % | % | |
| 1 | PBS buffer pH = 7.4 | 100 | 99 | 99 | 98 | 97 |
|
| EMEM FBS 10% P/S 1% (0.75 mL) + PBS (0.25 mL) | 100 | 100 | 100 | 94 | 94 |
| 3 | McCoy’s FBS 10% P/S 1% (0.75 mL) + PBS (0.25 mL) | 100 | 100 | 100 | 94 | 94 |
| 4 | Rat blood + heparin (0.75 mL) + PBS (0.25 mL) | 100 | 64 | 34 | 1.3 | 0 |
| 5 | Blood plasma + heparin (0.75 mL) + PBS (0.25 mL) | 100 | 100 | 100 | 100 | 100 |
Fig. 4UV–Vis spectra of fresh and month old samples held under natural light conditions
Fig. 5a Fluorescence vs. multiple excitation wavelengths; b The strongest fluorescence for the excitation at 410 nm (black) and PBS fluorescence (blue); inset shows fluorescence of PBS pH 7.4 buffer in larger scale; c Count in maximum absorption ~632 nm vs. excitation wavelength, inset shows proposed Jablonski diagram for this system (not in scale) (color figure online)
Fig. 6Viability of HT-29 (a) and FaDu (b) cell lines after 24, 48, and 72 h of incubation with PTMTC
Fig. 7Emission spectra of the membrane of HT-29 cell incubated with PTMTC for 24 h and stained with concanavaline A (black squares) and of the PTMTC suspension in medium (red circles). Inset: LSM image of a HT-29 cell taken in the lambda mode
Fig. 8Effect of PTMTC on activity of AlAT, AspAT, ALP, and LDH 3 days after i.p. and i.v. administration of tested compound at dose 250 µg/kg BW. *Significantly different from control, p < 0.05